NutritionFacts.org Video Podcast

Controversy Around FDA’s Approval of Biogen Alzheimer’s Drug, Aducanumab

10.23.2023 - By Michael Greger, M.D. FACLMPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

I discuss the safety and efficacy of the newest Alzheimer's drug treatments, aducanumab (Aduhelm) and lecanemab (Leqembi).

More episodes from NutritionFacts.org Video Podcast